These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation. van den Heuvel JK; Boon MR; van Hengel I; Peschier-van der Put E; van Beek L; van Harmelen V; van Dijk KW; Pereira AM; Hunt H; Belanoff JK; Rensen PC; Meijer OC Br J Pharmacol; 2016 Jun; 173(11):1793-804. PubMed ID: 26990179 [TBL] [Abstract][Full Text] [Related]
9. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids. Dryden S; Burns SJ; Frankish HM; Williams G Eur J Pharmacol; 1997 Dec; 340(2-3):221-5. PubMed ID: 9537819 [TBL] [Abstract][Full Text] [Related]
10. Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice. Kroon J; Koorneef LL; van den Heuvel JK; Verzijl CRC; van de Velde NM; Mol IM; Sips HCM; Hunt H; Rensen PCN; Meijer OC Endocrinology; 2018 Jan; 159(1):535-546. PubMed ID: 28938459 [TBL] [Abstract][Full Text] [Related]
11. Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats. Soro A; Panarelli M; Holloway CD; Fraser R; Kenyon CJ J Endocrinol Invest; 1995 Dec; 18(11):833-9. PubMed ID: 8778154 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism. Hattori T; Murase T; Iwase E; Takahashi K; Ohtake M; Tsuboi K; Ohtake M; Miyachi M; Murohara T; Nagata K Nagoya J Med Sci; 2013 Feb; 75(1-2):81-92. PubMed ID: 23544271 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line. Peeters BW; Ruigt GS; Craighead M; Kitchener P Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154 [TBL] [Abstract][Full Text] [Related]
15. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat. McCullers DL; Sullivan PG; Scheff SW; Herman JP Neuroscience; 2002; 109(2):219-30. PubMed ID: 11801359 [TBL] [Abstract][Full Text] [Related]
16. Mifepristone attenuates depression-like changes induced by chronic central administration of interleukin-1β in rats. Zhang YP; Wang HY; Zhang C; Liu BP; Peng ZL; Li YY; Liu FM; Song C Behav Brain Res; 2018 Jul; 347():436-445. PubMed ID: 29580890 [TBL] [Abstract][Full Text] [Related]
17. The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test. Solomon MB; Wulsin AC; Rice T; Wick D; Myers B; McKlveen J; Flak JN; Ulrich-Lai Y; Herman JP Horm Behav; 2014 Apr; 65(4):363-71. PubMed ID: 24530653 [TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress. Bechtold AG; Patel G; Hochhaus G; Scheuer DA Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1445-54. PubMed ID: 19279295 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486. Nagasawa K; Matsuura N; Takeshita Y; Ito S; Sano Y; Yamada Y; Uchinaka A; Murohara T; Nagata K Nutr Diabetes; 2016 Apr; 6(4):e207. PubMed ID: 27110688 [TBL] [Abstract][Full Text] [Related]
20. Dexamethasone decreases insulin-like growth factor-I and -II via a glucocorticoid receptor dependent mechanism in developing rat brain. Feng Y; Famuyide M; Bhatt AJ Neuro Endocrinol Lett; 2013; 34(7):624-34. PubMed ID: 24464002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]